Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.318NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.557ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.557ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.557ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.557NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.119ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.119ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.119ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.119NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.160ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.160ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.160ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.160NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
D.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
D.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
D.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.447ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.447ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.447ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.447NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.110.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.110.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.110.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.180ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.180ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.180ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.180NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.155ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.155ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.155ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.155NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.92ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.92ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.92ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.92NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.145ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.145ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.145NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.120ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.120ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.120NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.77ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.77NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used